文献速递瓣膜外科

二尖瓣置换术中超声乳化处理严重二尖瓣环钙化

Ultrasonic Emulsification of Severe Mitral Annular Calcification During Mitral Valve Replacement.
PubMed 文献 · Ann Thorac Surg · 2022-01-03

单中心回顾性分析2015年1月至2020年3月179例二尖瓣环钙化(MAC)行二尖瓣置换术(MVR)患者,其中2019年4月至2020年3月连续15例严重MAC(钙化≥50%瓣环)患者在MVR中辅助使用超声乳化/抽吸进行瓣环去钙化;该组无手术死亡或卒中,作者认为可能有助于降低MVR风险并促进手术成功。

要点

  • 严重MAC(≥50%瓣环)患者MVR术中辅助超声乳化/抽吸去钙化。
  • 超声乳化/抽吸组15例,无手术死亡或卒中。
  • 作者认为该技术可能有助于降低MVR风险并促进手术成功。

核心结论

  • 在严重MAC患者中,使用超声乳化与抽吸可能有助于降低MVR的风险并促进这一具有挑战性的高危人群的手术成功。

研究设计与样本

  • 单中心研究,排除既往二尖瓣手术或心内膜炎,2015年1月至2020年3月共179例MAC患者行MVR。
  • 其中2019年4月至2020年3月连续15例严重MAC(钙化≥50%瓣环)患者在MVR中辅助接受超声乳化/抽吸瓣环去钙化。

主要发现

  • 患者平均年龄68±12岁,72%(n=128)为女性。
  • 平均术前左心室射血分数60%±11%,平均二尖瓣跨瓣压差9.1±4.4 mm Hg。
  • 合并手术包括抗心律失常手术(n=52)、主动脉瓣置换(n=32)和冠状动脉旁路移植(n=20)。
  • 接受超声乳化与抽吸的患者组无手术死亡或卒中。

临床怎么用

  • 作者认为,在严重MAC患者中,超声乳化与抽吸的使用可能有助于降低MVR的风险并促进手术成功。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Severe mitral annular calcification (MAC) increases surgical complexity and is independently associated with increased operative mortality for mitral valve replacement (MVR). Recently we adopted ultrasonic emulsification/aspiration for annular decalcification to address these risks and describe our early experience with this new technology. DESCRIPTION: Excluding previous mitral valve surgery or endocarditis, 179 patients with MAC underwent MVR at a single institution between January 2015 and March 2020. Of these, 15 consecutive patients with severe MAC (≥50% of the annulus) underwent annular decalcification with ultrasonic emulsification/aspiration as an adjunct treatment during MVR from April 2019 to March 2020. EVALUATION: Mean patient age was 68 ± 12 years, and 72% (n = 128) were female. Mean preoperative left ventricular ejection fraction was 60% ± 11%, and mean mitral valve gradient was 9.1 ± 4.4 mm Hg. Concomitant procedures included antiarrhythmia (n = 52), aortic valve replacement (n = 32), and coronary artery bypass grafting (n = 20). There were no operative deaths or strokes in the group undergoing ultrasonic emulsification and aspiration. CONCLUSIONS: The use of ultrasonic emulsification and aspiration in severe MAC patients may help mitigate the risks of MVR and facilitate operative success in this challenging, high-risk population.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Brescia AA, Rosenbloom LM, Watt TMF, et al. Ultrasonic Emulsification of Severe Mitral Annular Calcification During Mitral Valve Replacement. Ann Thorac Surg. 2022. PMID: 34990573. doi:10.1016/j.athoracsur.2021.11.066

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。